PeptideVS
Cognitive Enhancement
Not submitted
Evidence: Moderate

Selank

Also known as: TP-7

Overview
Anxiety disorders and cognitive enhancement

Selank is a synthetic heptapeptide developed in Russia as an anxiolytic and nootropic agent. It has been shown to reduce anxiety without causing sedation or addiction, while potentially improving memory, learning, and attention. It is approved in Russia for anxiety disorders but is not FDA-approved.

Mechanism of Action

Synthetic peptide analog of tuftsin that modulates GABA, serotonin, and norepinephrine for anxiolytic effects

Dosage Information
ParameterDetail
AdministrationNasal spray
Typical Dose2-3 drops per nostril 2-3x daily
FrequencyDaily
Side Effects
Reported adverse effects from clinical data and post-market surveillance

Common Side Effects

Nasal irritation
Mild drowsiness
Headache

Serious Side Effects

Unknown long-term effects
Limited safety data
!Contraindications
Do not use this peptide if any of the following apply
  • Pregnancy
  • Breastfeeding
  • Children
Clinical Evidence

Evidence Quality

Moderate

Clinical Trial Phase

Preclinical / Not submitted

View Key Study
Cost Comparison
Estimated monthly costs compared to similar peptides
PeptideMonthly CostFDA Status
Selank$40 - $80/mo
Not submitted
Semax$45 - $90/mo
Not submitted
Compare Selank
See how Selank stacks up against similar peptides
Selank vs Semax

Medical Disclaimer

The information provided on this page is for educational and informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or modifying any peptide therapy or medication. PeptideVS does not endorse, recommend, or promote the use of any specific peptide for medical treatment. Clinical data cited may be from ongoing trials and is subject to change. Individual results may vary.